We wrote in the year-end letter about the negative experience the fund had with Colfax (NYSE:CFX) in 2015. Our experience has been more favorable so far in 2016, but we caution that we are not out of the woods yet. The outlook for industrial end-markets around the world, especially in emerging markets, remains uncertain. Nonetheless, some of the pessimism has eased and the stock market has responded accordingly with the share price smartly off the lows of earlier this year. Our original thesis concerning the company and its founding sponsors, Mitchell and Steven Rales, remains unchanged!
From Akre Focus Fund commentary first quarter 2016.
